Abbott Laboratories (ABL)
Summary
ABL Chart
Abbott: Bear Trap Over, With Richer Return Prospects
ABT's diversified diagnostics/nutrition/medtech segments drive multi-pronged growth prospects, as the management targets a +7% organic growth rate. The recent EXAS acquisition introduces balance sheet/bottom-line risks, albeit with the new Cancer Diagnostic segment delivering double-digit growth rates. The prior meltdown unlocks the cheap valuations, the richer dividend yields, and the excellent upside potential to my bull-case LTPT of $139.
ABT Q2 Earnings Call Flags Stronger Second-Half Setup
Abbott's raised 2026 earnings outlook and four growth drivers point to a faster second half across nutrition, devices, diagnostics and diabetes care.
Abbott Laboratories (ABT) Q2 2026 Earnings Call Transcript
Abbott Laboratories (ABT) Q2 2026 Earnings Call Transcript
Abbott Laboratories (ABL) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Abbott Laboratories ever had a stock split?
Abbott Laboratories Profile
| Pharmaceuticals Industry | Healthcare Sector | Robert Ford CEO | XFRA Exchange | 002824100 CUSIP |
| US Country | 114,000 Employees | 15 Jul 2026 Last Dividend | 2 Jan 2013 Last Split | 13 Jan 1978 IPO Date |
Overview
Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.
Products and Services
Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains:
- Generic Pharmaceuticals: Includes treatments for pancreatic exocrine insufficiency, irritable bowel syndrome, biliary spasm, intrahepatic cholestasis, depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease, vestibular vertigo, pain, fever, inflammation, migraine, anti-infective clarithromycin, influenza vaccine, and colon rhythm regulation products.
- Diagnostic Products: Offers laboratory and transfusion medicine systems in areas such as immunoassay, clinical chemistry, hematology, and transfusion. Includes molecular diagnostics for DNA and RNA processing and detection of infectious agents, point-of-care systems, blood gas testing cartridges, rapid diagnostics, molecular point-of-care testing for several diseases, cardiometabolic tests, drug and alcohol tests, remote patient monitoring, consumer self-tests, and laboratory automation and informatics solutions.
- Nutritional Products: Provides nutritional products for both pediatric and adult use, catering to the specific dietary needs of different age groups and health conditions.
- Medical Devices: Offers a wide array of devices for the treatment of cardiovascular diseases, including rhythm management, electrophysiology, heart failure, vascular, and structural heart devices. Additionally, the company develops diabetes care products such as blood glucose monitoring systems, along with neuromodulation devices for managing chronic pain and movement disorders.
